|
ZNF782 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.312200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.115600E-01 |
| Normal-vs-Stage2 |
7.157600E-01 |
| Normal-vs-Stage3 |
2.790100E-02 |
| Normal-vs-Stage4 |
1.156030E-03 |
| Stage1-vs-Stage2 |
5.123400E-01 |
| Stage1-vs-Stage3 |
5.003900E-03 |
| Stage1-vs-Stage4 |
2.361600E-04 |
| Stage2-vs-Stage3 |
3.190600E-01 |
| Stage2-vs-Stage4 |
8.153900E-02 |
| Stage3-vs-Stage4 |
2.508600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.553800E-01 |
| Normal-vs-AfricanAmerican |
2.786600E-01 |
| Normal-vs-Asian |
8.319000E-01 |
| Caucasian-vs-AfricanAmerican |
6.846800E-01 |
| Caucasian-vs-Asian |
6.715400E-01 |
| AfricanAmerican-vs-Asian |
5.482200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.839200E-03 |
| Normal-vs-Female |
1.351850E-01 |
| Male-vs-Female |
2.56860000003023E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.317760E-01 |
| Normal-vs-Age(41-60Yrs) |
8.954400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.856300E-02 |
| Normal-vs-Age(81-100Yrs) |
4.607000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.476400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.021400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.002200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.133800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.319800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.073400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.320500E-03 |
| Normal-vs-Grade 2 |
2.090800E-01 |
| Normal-vs-Grade 3 |
6.169900E-02 |
| Normal-vs-Grade 4 |
1.23819999808816E-08 |
| Grade 1-vs-Grade 2 |
1.402020E-01 |
| Grade 1-vs-Grade 3 |
3.578100E-03 |
| Grade 1-vs-Grade 4 |
1.74990000045838E-07 |
| Grade 2-vs-Grade 3 |
9.383900E-04 |
| Grade 2-vs-Grade 4 |
4.72111238991602E-12 |
| Grade 3-vs-Grade 4 |
4.18869999996296E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.390000E-04 |
| Normal-vs-ccB subtype |
3.0269999995447E-07 |
| ccA subtype-vs-ccB subtype |
1.62447832963153E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.354600E-01 |
| Normal-vs-N1 |
4.19289999999961E-05 |
| N0-vs-N1 |
1.002240E-03 |
|
|
